The State Council meeting reviewed and approved the "Regulations on the Management of Clinical Research and Clinical Transformation Application of Biomedical New Technologies".

Li Qiang chaired the State Council executive meeting and reviewed and passed the "Regulations on the Management of Clinical Research and Clinical Transformation Application of Biomedical New Technologies." The meeting pointed out that it is necessary to promote the innovation and development of China's biomedical technology, accelerate technological research and development, and the application of results transformation, promote the high-quality development of the biomedical industry, and focus on shaping new advantages for development. It is necessary to adhere to the principle of balancing development and safety, regulate clinical research in accordance with the law, ensure the quality and safety of clinical applications, effectively prevent various risks, and ensure that innovative achievements better promote the health and well-being of the people.